Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Recruitment Status: Recruiting
Start Date: March 29, 2021
End Date: January 01, 2028
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Inclusion Criteria:
- Patients 18 years and older
- Written informed consent (patient data release-form)
- Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide
Exclusion Criteria:
- Life expectancy of <1 year
-
Conditions:
- Peripheral Vascular Diseases